ARTICLE
8 May 2024

DEA Moves To Reclassify Marijuana As A Schedule III Drug

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry.
United States Cannabis & Hemp
David M. DiGiacomo’s articles from Michael Best are most popular:
  • in United States
Michael Best are most popular:
  • within Employment and HR topic(s)
  • with readers working within the Retail & Leisure industries

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry. Additionally rescheduling would lift the burden of 280E from legal cannabis operators. Regulatory change will involve notice and comment rulemaking - a potentially lengthy process - we will continue to follow as this develops.

US drug control agency will move to reclassify marijuana in a historic shift, AP sources say

apnews.com/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More